share_log

诺泰生物(688076.SH):替尔泊肽原料药处于工艺验证阶段

Notch Biopharma (688076.SH): The active pharmaceutical ingredient of telbivudine is in the process validation stage.

Gelonghui Finance ·  Aug 9 05:12

On August 9th, Gelunhui reported that Notai Biology (688076.SH) stated on their interactive platform that the technology verification stage has been reached with their active pharmaceutical ingredient, Telbivudine, which can be used for customer research and development approval. Sales revenues of 59.4246 million yuan have been generated in 2023.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment